Saturday, 17 October 2026European Markets

AURES TECHNOLOGIES Stock Rises By 23% In The Last 10 Sessions

Loading stream...

(vianews) - shares of aures technologies (cac 40: aurs.pa) jumped by a staggering 23.61% in 10 sessions from €5.76 to €7.12 at 11:38 est on thursday, following the last session's downward trend. cac 40 is dropping 0.43% to €7,517.02, after two consecutive sessions in a row of gains.

about aures technologies

aures technologies s.a. engages in manufacture of hardware and digital application solutions for point of sale and retail industry. the company provides all-in-one touch screen terminals, pos systems, and retail solutions; kiosk products; pos and mobile tablets; touchscreen panels; pos thermal receipt printers; complementary screens, displays, and monitors; and a range of accessories, such as barcode scanners, specific readers for magnetic cards, biometric readers, and rfid readers. it also offers consulting, staging, installation, decommissioning, asset tracking, real time pos monitoring, and onsite support services. the company offers its products for food and non-food stores, shops, retail outlets, superstores and supermarkets, catering and hospitality businesses, snacking and takeaway outlets, leisure and sport venues, etc. it markets its products through a network of distributors, resellers, agents, and partners in france, the united kingdom, germany, australia, the united states, and internationally. the company was incorporated in 1989 and is headquartered in lisses, france.

earnings per share

as for profitability, aures technologies has a trailing twelve months eps of €0.37.

pe ratio

aures technologies has a trailing twelve months price to earnings ratio of 19.45. meaning, the purchaser of the share is investing €19.45 for every euro of annual earnings.

more news about aures technologies (aurs.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com